Mark Chang, PhD, is the founder of AGInception and an adjunct professor of Biostatistics at Boston University. He is an elected fellow of the American Statistical Association, a co-founder of the International Society for Biopharmaceutical Statistics. He previously held various positions in pharmaceutical companies, including Scientific Fellow, executive Director, and Senior Vice President. He is an adaptive design expert and has extensive knowledge in AI for clinical trials. He has published 12 books on artificial intelligence & machine learning, adaptive clinical trial designs, biostatistics, and scientific principles.